Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Orifarm AS

02 3Roche Pharma (Switzerland) Ag

03 3Roche Registration GmbH

04 11Roche Registration Gmbh

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Organic Process R&D
Not Confirmed
arrow
arrow
Organic Process R&D
Not Confirmed

Atezolizumab

Brand Name : Tecentriq

Dosage Form : Concentrate for infusion solution, solution

Dosage Strength : 1,200 mg

Packaging : Vials 1 20ml

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

02

Organic Process R&D
Not Confirmed
arrow
arrow
Organic Process R&D
Not Confirmed

Atezolizumab

Brand Name : Tecentriq

Dosage Form : Solution for injection

Dosage Strength : 1,875 mg

Packaging : Vials 1 15ml

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

03

Organic Process R&D
Not Confirmed
arrow
arrow
Organic Process R&D
Not Confirmed

Atezolizumab

Brand Name : Tecentriq

Dosage Form : Concentrate for infusion solution, solution

Dosage Strength : 840 mg

Packaging : Vials 1 14ml

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

04

Organic Process R&D
Not Confirmed
arrow
arrow
Organic Process R&D
Not Confirmed

Atezolizumab

Brand Name : Tecentriq

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 1200mg

Packaging :

Approval Date : 21/09/2017

Application Number : 20160430000118

Regulatory Info : Approved

Registration Country : Sweden

blank

05

Organic Process R&D
Not Confirmed
arrow
arrow
Organic Process R&D
Not Confirmed

Atezolizumab

Brand Name : Tecentriq

Dosage Form : Injectable Solution

Dosage Strength : 1875mg

Packaging :

Approval Date : 18/01/2024

Application Number : 20221116000072

Regulatory Info : Approved

Registration Country : Sweden

blank

06

Organic Process R&D
Not Confirmed
arrow
arrow
Organic Process R&D
Not Confirmed

Atezolizumab

Brand Name : Tecentriq

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 840mg

Packaging :

Approval Date : 26/08/2019

Application Number : 20180914000090

Regulatory Info : Approved

Registration Country : Sweden

blank

07

Organic Process R&D
Not Confirmed
arrow
arrow
Organic Process R&D
Not Confirmed

Atezolizumab

Brand Name : Tecentriq

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 1200mg/20ml

Packaging :

Approval Date : 23/05/2017

Application Number : 66152

Regulatory Info : Allowed

Registration Country : Switzerland

blank

08

Organic Process R&D
Not Confirmed
arrow
arrow
Organic Process R&D
Not Confirmed

Atezolizumab

Brand Name : Tecentriq

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 840mg/14ml

Packaging :

Approval Date : 23/05/2017

Application Number : 66152

Regulatory Info : Allowed

Registration Country : Switzerland

blank

09

Organic Process R&D
Not Confirmed
arrow
arrow
Organic Process R&D
Not Confirmed

Atezolizumab

Brand Name : Tecentriq

Dosage Form : Concentrate for infusion solution, solution

Dosage Strength : 840 mg

Packaging : Vials 1 14ml

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

10

Organic Process R&D
Not Confirmed
arrow
arrow
Organic Process R&D
Not Confirmed

Atezolizumab

Brand Name : Tecentriq

Dosage Form : Concentrate for infusion solution, solution

Dosage Strength : 1,200 mg

Packaging : Vials 1 20ml

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank